The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2024 | Getting involved in real-world studies for CLL through ERIC
Celso Arrais, MD, PhD, Federal University of São Paulo, São Paulo, Brazil, discusses the importance of real-world studies of chronic lymphocytic leukemia (CLL). He emphasizes the role of ERIC in collaborating with physicians globally to enhance data collection and interpretation, making the findings more reliable. This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
